Follow
Christopher S Towler
Christopher S Towler
Verified email at novartis.com
Title
Cited by
Cited by
Year
Allosteric inhibition of SHP2: identification of a potent, selective, and orally efficacious phosphatase inhibitor
J Garcia Fortanet, CHT Chen, YNP Chen, Z Chen, Z Deng, B Firestone, ...
Journal of medicinal chemistry 59 (17), 7773-7782, 2016
2592016
Impact of molecular speciation on crystal nucleation in polymorphic systems: The conundrum of γ glycine and molecular ‘self poisoning'
CS Towler, RJ Davey, RW Lancaster, CJ Price
Journal of the American Chemical Society 126 (41), 13347-13353, 2004
2212004
Crystallization in polymorphic systems: the solution-mediated transformation of β to α glycine
ES Ferrari, RJ Davey, WI Cross, AL Gillon, CS Towler
Crystal growth & design 3 (1), 53-60, 2003
1882003
Identification of TNO155, an allosteric SHP2 inhibitor for the treatment of cancer
MJ LaMarche, M Acker, A Argintaru, D Bauer, J Boisclair, H Chan, ...
Journal of medicinal chemistry 63 (22), 13578-13594, 2020
1302020
Discovery of small molecule splicing modulators of survival motor neuron-2 (SMN2) for the treatment of spinal muscular atrophy (SMA)
AK Cheung, B Hurley, R Kerrigan, L Shu, DN Chin, Y Shen, G O’Brien, ...
Journal of medicinal chemistry 61 (24), 11021-11036, 2018
1222018
The crystallization of glycine polymorphs from emulsions, microemulsions, and lamellar phases
K Allen, RJ Davey, E Ferrari, C Towler, GJ Tiddy, MO Jones, RG Pritchard
Crystal growth & design 2 (6), 523-527, 2002
972002
6-Amino-3-methylpyrimidinones as potent, selective, and orally efficacious SHP2 inhibitors
P Sarver, M Acker, JT Bagdanoff, Z Chen, YN Chen, H Chan, B Firestone, ...
Journal of medicinal chemistry 62 (4), 1793-1802, 2019
832019
Optimization of fused bicyclic allosteric SHP2 inhibitors
JT Bagdanoff, Z Chen, M Acker, YN Chen, H Chan, M Dore, B Firestone, ...
Journal of medicinal chemistry 62 (4), 1781-1792, 2019
662019
An investigation into the influence of counterion on the properties of some amorphous organic salts
CS Towler, T Li, H Wikström, DM Remick, MV Sanchez-Felix, LS Taylor
Molecular pharmaceutics 5 (6), 946-955, 2008
372008
The influence of aqueous content in small scale salt screening—improving hit rate for weakly basic, low solubility drugs
PB Tarsa, CS Towler, G Woollam, J Berghausen
European journal of pharmaceutical sciences 41 (1), 23-30, 2010
352010
Spectroscopic characterization of intermolecular interactions in solution and their influence on crystallization outcome
CS Towler, LS Taylor
Crystal growth & design 7 (4), 633-638, 2007
332007
A novel selective soluble guanylate cyclase activator, MGV354, lowers intraocular pressure in preclinical models, following topical ocular dosing
G Prasanna, L Ferrara, C Adams, T Ehara, B Li, L Yang, C Xiang, CTH Ng, ...
Investigative Ophthalmology & Visual Science 59 (5), 1704-1716, 2018
192018
The Discovery of (S)-1-(6-(3-((4-(1-(Cyclopropanecarbonyl)piperidin-4-yl)-2-methylphenyl)amino)-2,3-dihydro-1H-inden-4-yl)pyridin-2-yl)-5-methyl-1H-pyrazole-4 …
T Ehara, CM Adams, D Bevan, N Ji, EL Meredith, DB Belanger, J Powers, ...
Journal of medicinal chemistry 61 (6), 2552-2570, 2018
152018
Quinazolinone derivatives useful as vanilloid antagonists
W Chen, HY Kim, J Liang, M Mutz, M Prashad, C Towler, R Wu
US Patent 8,349,852, 2013
82013
R. f. Da2ey, RX kancaster, C. f. Price, Impact o> Molecular Speciation on Crystal Nucleation in Polymorphic SystemsI The Conundrum o>" Glycine and Molecular xSel> Poisoningx
CS Towler
Journal of the American Chemical Society 126, 13347, 2004
72004
Counterion quantification for discovery chemistry and pre-formulation salt screening
J Reilly, P Wright, J Larrow, T Mann, J Twomey, M Grondine, S Dodd, ...
Journal of liquid chromatography & related technologies 35 (8), 1001-1010, 2012
42012
Early Intervention with Formulation Strategies for Multidimensional Problems to Optimize for Success
S Dodd, C Capacci‐Daniel, C Towler, R Panicucci, K Hoffmaster
Predictive ADMET: Integrative Approaches in Drug Discovery and Development …, 2014
12014
Nucleation in polymorphic systems
C Towler
The University of Manchester, 2004
12004
Derivados de quinazolinona útiles como antagonistas de vanilloides
W Chen, HY Kim, J Liang, M Mutz, M Prashad, C Towler, R Wu
2017
Quinazolinone derivatives useful as vanilloid antagonists
W Chen, HY Kim, J Liang, M Mutz, M Prashad, C Towler, R Wu
US Patent App. 13/612,259, 2013
2013
The system can't perform the operation now. Try again later.
Articles 1–20